Scientific Reports (Feb 2022)

Cell surface expression of GRP78 and CXCR4 is associated with childhood high-risk acute lymphoblastic leukemia at diagnostics

  • Tania Angeles-Floriano,
  • Guadalupe Rivera-Torruco,
  • Paulina García-Maldonado,
  • Esmeralda Juárez,
  • Yolanda Gonzalez,
  • Israel Parra-Ortega,
  • Armando Vilchis-Ordoñez,
  • Briceida Lopez-Martinez,
  • Lourdes Arriaga-Pizano,
  • Dario Orozco-Ruíz,
  • José Refugio Torres-Nava,
  • Paula Licona-Limón,
  • Francisco López-Sosa,
  • Alhelí Bremer,
  • Lourdes Alvarez-Arellano,
  • Ricardo Valle-Rios

DOI
https://doi.org/10.1038/s41598-022-05857-w
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Acute lymphocytic leukemia is the most common type of cancer in pediatric individuals. Glucose regulated protein (GRP78) is an endoplasmic reticulum chaperone that facilitates the folding and assembly of proteins and regulates the unfolded protein response pathway. GRP78 has a role in survival of cancer and metastasis and cell-surface associated GRP78 (sGRP78) is expressed on cancer cells but not in normal cells. Here, we explored the presence of sGRP78 in pediatric B-ALL at diagnosis and investigated the correlation with bona fide markers of leukemia. By using a combination of flow cytometry and high multidimensional analysis, we found a distinctive cluster containing high levels of sGRP78, CD10, CD19, and CXCR4 in bone marrow samples obtained from High-risk leukemia patients, which was absent in the compartment of Standard-risk leukemia. We confirmed that sGRP78+CXCR4+ blood-derived cells were more frequent in High-risk leukemia patients. Finally, we analyzed the dissemination capacity of sGRP78 leukemia cells in a model of xenotransplantation. sGRP78+ cells emigrated to the bone marrow and lymph nodes, maintaining the expression of CXCR4. Testing the presence of sGRP78 and CXCR4 together with conventional markers may help to achieve a better categorization of High and Standard-risk pediatric leukemia at diagnosis.